Kattalai Kailasam Vasanth, Chima Victoria, Nnamdi Uchechukwu, Sharma Kavita, Shah Kairav
College of Medicine, University of Illinois, Chicago, IL, USA.
Mount Sinai Beth Israel Medical Center, New York, NY, USA.
Neuropsychiatr Dis Treat. 2017 Jul 25;13:1975-1977. doi: 10.2147/NDT.S141472. eCollection 2017.
This case report presents a 44-year-old man with a history of schizophrenia who developed neutropenia on risperidone therapy. The patient's laboratory reports showed a gradual decline of leukocytes and neutrophils after resolution and rechallenging. This was reversed with the discontinuation of risperidone and by switching to olanzapine. In this case report, we also discuss the updated evidence base for management of risperidone-induced neutropenia.
本病例报告介绍了一名44岁有精神分裂症病史的男性,其在接受利培酮治疗时出现了中性粒细胞减少症。患者的实验室报告显示,在缓解和再次用药后白细胞和中性粒细胞逐渐下降。停用利培酮并换用奥氮平后这种情况得到了逆转。在本病例报告中,我们还讨论了利培酮所致中性粒细胞减少症管理的最新证据基础。